Published in Mol Gen Genet on January 01, 1980
Classification of Histoplasma capsulatum isolates by restriction fragment polymorphisms. J Bacteriol (1986) 4.55
Has the endosymbiont hypothesis been proven? Microbiol Rev (1982) 3.86
Repetitive DNA of Candida albicans: nuclear and mitochondrial components. J Bacteriol (1984) 2.52
Structure and evolution of organelle genomes. Microbiol Rev (1982) 2.11
Linear mitochondrial deoxyribonucleic acid from the yeast Hansenula mrakii. Mol Cell Biol (1981) 1.37
Structure and sequence of the mitochondrial 20S rRNA and tRNA tyr gene of Paramecium primaurelia. Nucleic Acids Res (1981) 1.19
Organization and closing of mitochondrial deoxyribonucleic acid from Paramecium tetraaurelia and Paramecium primaurelia. Mol Cell Biol (1981) 0.77
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell (1990) 8.00
Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science (2000) 6.16
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J (1996) 5.17
The ETS-domain: a new DNA-binding motif that recognizes a purine-rich core DNA sequence. Genes Dev (1990) 4.46
PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity. Mol Cell Biol (1992) 3.32
Complete primary structures of the E beta chain and gene of the mouse major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 3.09
Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med (1985) 3.00
Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor. Science (1986) 2.84
Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol (1996) 2.79
The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J Biol Chem (1987) 2.78
Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor. J Biol Chem (1988) 2.46
Cleavage of head and tail proteins during bacteriophage T5 assembly: selective host involvement in the cleavage of a tail protein. J Mol Biol (1973) 2.37
Fine structure analysis and nucleotide sequence of the vaccinia virus thymidine kinase gene. Proc Natl Acad Sci U S A (1983) 2.35
The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J Biol Chem (1993) 2.20
Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev (1998) 2.19
High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun (1992) 2.17
A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex. Nature (1996) 2.17
Effect of IL-7 on the growth of fetal thymocytes in culture. J Immunol (1989) 2.11
Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med (1997) 2.10
Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science (1993) 2.06
Electron microscopic evidence for linear insertion of bacteriophage MU-1 in lysogenic bacteria. J Virol (1971) 2.00
In vivo interleukin 2 administration augments the generation of alloreactive cytolytic T lymphocytes and resident natural killer cells. J Immunol (1983) 1.97
Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma. J Exp Med (1987) 1.85
Development and characterization of antiserum to murine granulocyte-macrophage colony-stimulating factor. J Immunol (1986) 1.80
A rapid biologic assay for the detection of interleukin 1. J Immunol (1983) 1.77
Human interleukin 1. Purification to homogeneity. J Exp Med (1985) 1.72
Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen. J Biol Chem (1986) 1.71
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest (2001) 1.70
Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc Natl Acad Sci U S A (1987) 1.65
Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res (2001) 1.59
Methylated bases in DNA from Paramecium aurelia. Biochim Biophys Acta (1974) 1.57
Characterization of the ets oncogene family member, fli-1. J Biol Chem (1993) 1.57
Control of experimental contact sensitivity. Adv Immunol (1980) 1.54
The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol (2000) 1.53
Molecular characterization of interleukin 2. Immunol Rev (1982) 1.52
Lymphokine purification by reversed-phase high-performance liquid chromatography. J Chromatogr (1984) 1.51
Are mitochondrial structural genes selectively amplified during senescence in Podospora anserina? Cell (1982) 1.50
A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol (2006) 1.49
Paramecium mitochondrial genes. I. Small subunit rRNA gene sequence and microevolution. J Biol Chem (1984) 1.48
Integration of mitochondrial gene sequences within the nuclear genome during senescence in a fungus. Nature (1983) 1.46
Mitochondrial DNA from Podospora anserina. II. Properties of mutant DNA and multimeric circular DNA from senescent cultures. Mol Gen Genet (1979) 1.42
Tracts of high or low sequence divergence in the mouse major histocompatibility complex. EMBO J (1984) 1.42
Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J Immunol (2000) 1.42
Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23). J Biol Chem (1994) 1.41
Differentiation of the mononuclear phagocyte system during mouse embryogenesis: the role of transcription factor PU.1. Blood (1999) 1.41
Thymineless death in Escherichia coli: strain specificity. J Bacteriol (1967) 1.40
Analysis of class I introns in a mitochondrial plasmid associated with senescence of Podospora anserina reveals extraordinary resemblance to the Tetrahymena ribosomal intron. Curr Genet (1985) 1.40
Structure and replication of mitochondrial DNA from Paramecium aurelia. J Mol Biol (1975) 1.38
Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease. Exp Neurol (1999) 1.36
Disruption of T-even bacteriophages by dimethyl sulfoxide. J Virol (1968) 1.36
Myeloid development is selectively disrupted in PU.1 null mice. Blood (1998) 1.33
Localization of human mononuclear cell interleukin 1. J Immunol (1987) 1.33
Mitochondrial DNA from Podospora anserina. I. Isolation and characterization. Mol Gen Genet (1979) 1.32
Paramecium mitochondrial genes. II. Large subunit rRNA gene sequence and microevolution. J Biol Chem (1984) 1.29
Regulation of the PU.1 gene by distal elements. Blood (2001) 1.28
Mesenchymal cells engulf and clear apoptotic footplate cells in macrophageless PU.1 null mouse embryos. Development (2000) 1.28
Thymineless death in Escherichia coli: deoxyribonucleic acid replication and the immune state. J Bacteriol (1970) 1.27
Nucleotide sequence of the mitochondrial genome of Paramecium. Nucleic Acids Res (1990) 1.25
Activation of transcription by PU.1 requires both acidic and glutamine domains. Mol Cell Biol (1996) 1.22
Structural proteins of bacteriophage T5. Virology (1973) 1.22
Structural aberrations in T-even bacteriophage. II. Characterization of the proteins contained in aberrant heads. Virology (1971) 1.21
Excision-amplification of mitochondrial DNA during senescence in Podospora anserina. DNA sequence analysis of three unique "plasmids". J Mol Biol (1985) 1.20
Mitochondrial DNA replication in Paramecium aurelia. Cross-linking of the initiation end. J Mol Biol (1977) 1.20
Structure and sequence of the mitochondrial 20S rRNA and tRNA tyr gene of Paramecium primaurelia. Nucleic Acids Res (1981) 1.19
Characterization of gamma-aminobutyric acid receptor GABAB(1e), a GABAB(1) splice variant encoding a truncated receptor. J Biol Chem (2000) 1.18
Structural aberrations in T-even bacteriophage. 3. Induction of "lollipops" and their partial characterization. Virology (1973) 1.18
Thymineless death in Escherichia coli: inactivation and recovery. J Bacteriol (1969) 1.18
Cytokine-dependent thymocyte responses: characterization of IL 1 and IL 2 target subpopulations and mechanism of action. J Immunol (1982) 1.18
Linkage of a gene causing familial focal segmental glomerulosclerosis to chromosome 11 and further evidence of genetic heterogeneity. Genomics (1999) 1.17
Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis (1997) 1.17
Studies on Macronuclear DNA from Paramecium aurelia. Chromosoma (1975) 1.15
Neutrophils deficient in PU.1 do not terminally differentiate or become functionally competent. Blood (1998) 1.14
Nephroblastoma overexpressed gene (NOV) codes for a growth factor that induces protein tyrosine phosphorylation. Gene (1999) 1.13
Identification of a nuclear factor that binds to a conserved sequence of the I-A beta gene. J Immunol (1988) 1.12
PU.1 but not ets-2 is essential for macrophage development from embryonic stem cells. Blood (1996) 1.11
Characterization of T-even bacteriophage substructures. I. Tail fibers and tail tubes. J Virol (1970) 1.11
Synchronization of E. coli K 12 by membrane selection. Biochem Biophys Res Commun (1970) 1.11
Replication of linear mitochondrial DNA from Paramecium: sequence and structure of the initiation-end crosslink. Proc Natl Acad Sci U S A (1981) 1.11
The sedimentation and conformational variance among T-even bacteriophages. Virology (1969) 1.11
ADAMTS9, a novel member of the ADAM-TS/ metallospondin gene family. Genomics (2000) 1.10
Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors. Mol Endocrinol (1997) 1.09
Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope. Scand J Immunol (2006) 1.09
Amelioration of relapsing experimental autoimmune encephalomyelitis with altered myelin basic protein peptides involves different cellular mechanisms. J Neuroimmunol (1997) 1.09
Interferon-gamma activates multiple pathways to regulate the expression of the genes for major histocompatibility class II I-A beta, tumor necrosis factor and complement component C3 in mouse macrophages. Eur J Immunol (1989) 1.07
DNA binding of the mouse class II major histocompatibility CCAAT factor depends on two components. Mol Cell Biol (1989) 1.06
Density-gradient banding of denatured deoxyribonucleic acid in cesium sulphate. Biochim Biophys Acta (1966) 1.06
Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration. J Immunol (1999) 1.05
Expression and activity of ADAMTS-5 in synovium. Eur J Biochem (2001) 1.05
The transcription factor PU.1 is involved in macrophage proliferation. J Exp Med (1996) 1.05
Structural defects of T-even bacteriophages. Adv Virus Res (1970) 1.04
Induced structural defects in T-even bacteriophage. J Virol (1967) 1.04
Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J Immunol (1997) 1.03
Purification to homogeneity of a human hematopoietic growth factor that stimulates the growth of a murine interleukin 3-dependent cell line. J Immunol (1986) 1.02
Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J (1998) 1.01
New insights on DNA recognition by ets proteins from the crystal structure of the PU.1 ETS domain-DNA complex. J Biol Chem (1996) 1.00
A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done. J Hosp Infect (2011) 1.00
Efficient induction of immediate tolerance to contact sensitivity by hapten-modified spleen cells requires Ia+ cells compatible with recipient. Nature (1979) 0.99
Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int (1998) 0.99